The US Food and Drug Administration (FDA) is planning to regulate the use of the cannabis compound CBD in food and supplements after weighing the evidence on the compound's safety.
The FDA will decide whether regulating legal cannabis will require new agency rules or new legislation from Congress.
Cannabis products, excluding Epidiolex, are illegal at the federal level in the US, although some states allow their use.
According to Patrick Cournoyer, who heads the FDA office developing the agency's cannabis strategy, the FDA will ascertain if CBD can be safely eaten every day for a long period or during pregnancy amid concerns about future fertility.
.


Apple Appoints Amar Subramanya as New Vice President of AI Amid Push to Accelerate Innovation
Japan’s Service Sector Sustains Growth Momentum in November
Dollar Slips as Weak U.S. Manufacturing Data Increases Pressure for Fed Rate Cuts
Netanyahu Seeks Presidential Pardon Amid Ongoing Corruption Trial
Eli Lilly Becomes First Pharma Giant to Hit $1 Trillion Amid Soaring Weight-Loss Drug Demand
BOJ Governor Ueda Highlights Uncertainty Over Future Interest Rate Hikes
U.S. Backs Bayer in Supreme Court Battle Over Roundup Cancer Lawsuits
Bolsonaro Detained Over Alleged Escape Risk After Ankle Monitor Tampering
Trump Signs Executive Order to Boost AI Research in Childhood Cancer
EU Prepares Antitrust Probe Into Meta’s AI Integration on WhatsApp
Tesla Faces 19% Drop in UK Registrations as Competition Intensifies
Michael Dell Pledges $6.25 Billion to Boost Children’s Investment Accounts Under Trump Initiative
States Sue Trump Administration Over SNAP Restrictions for Legal Immigrants
Magnum Audit Flags Governance Issues at Ben & Jerry’s Foundation Ahead of Spin-Off
Chicago Rejects New Federal Violence Prevention Grants After Policy Shift
UN General Assembly Demands Russia Return Ukrainian Children Amid Ongoing Conflict 



